<?xml version="1.0"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/"><rdf:Description rdf:about="https://dirros.openscience.si/IzpisGradiva.php?id=29847"><dc:title>Morphological and functional parameters in X-linked retinoschisis patients</dc:title><dc:creator>Kiraly,	Peter	(Avtor)
	</dc:creator><dc:creator>Seitz,	Immanuel P.	(Avtor)
	</dc:creator><dc:creator>Abdalla Elsayed,	Maram E. A.	(Avtor)
	</dc:creator><dc:creator>Downes,	Susan	(Avtor)
	</dc:creator><dc:creator>Patel,	Chetan B.	(Avtor)
	</dc:creator><dc:creator>Birtel,	Johannes	(Avtor)
	</dc:creator><dc:creator>Mautone,	Luca	(Avtor)
	</dc:creator><dc:creator>Dulz,	Simon	(Avtor)
	</dc:creator><dc:creator>Vrabič,	Nika	(Avtor)
	</dc:creator><dc:creator>Jarc-Vidmar,	Martina	(Avtor)
	</dc:creator><dc:creator>Hawlina,	Marko	(Avtor)
	</dc:creator><dc:description>Introduction: X-linked retinoschisis (XLRS) is a potential target for gene supplementation approaches. To establish potential structural and functional endpoints for clinical trials, a comprehensive understanding of the intereye symmetry, relationship between structural and functional parameters, and disease progression is vital. Methods: In this retrospective multicentre study, 118 eyes of 59 XLRS patients with RS1 mutations were assessed. Information from center databases included: RS1 variant; age at presentation; best-corrected visual acuity (BCVA), central retinal thickness (CRT), macular volume (MV) at presentation and at the last follow up; full-field electroretinogram (ERG) findings; presence of peripheral retinoschisis and complications (vitreous hemorrhage, retinal detachment); treatment with systemic or topical carbonic anhydrase inhibitors (CAI). Results: Inter-eye symmetry revealed strong correlation in CRT (r = 0.77; p &lt; 0.0001) and moderate correlations in MV (r = 0.51, p &lt; 0.0001) and BCVA (r = 0.49; p &lt; 0.0001). Weak or no correlations were observed between BCVA and structural parameters (CRT, MV). Peripheral retinoschisis was observed in 40 (68%), retinal detachment in 9 (15%), and vitreous hemorrhage in 5 (8%) patients, respectively. Longitudinal examinations (mean, 4.3 years) showed no BCVA changes; however, a reduction of the CRT (p = 0.02), and MV (p = 0.01) was observed. Oral and/or topical CAI treatment did not significantly alter the CRT (p = 0.34).</dc:description><dc:date>2024</dc:date><dc:date>2026-06-08 12:57:53</dc:date><dc:type>Neznano</dc:type><dc:identifier>29847</dc:identifier><dc:language>sl</dc:language></rdf:Description></rdf:RDF>
